CRANE NXT CO (CXT) Stock Fundamental Analysis

NYSE:CXT • US2244411052

48.29 USD
-1.17 (-2.37%)
At close: Feb 27, 2026
48.29 USD
0 (0%)
After Hours: 2/27/2026, 8:04:00 PM
Fundamental Rating

6

Taking everything into account, CXT scores 6 out of 10 in our fundamental rating. CXT was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. CXT scores excellent on profitability, but there are concerns on its financial health. CXT may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • CXT had positive earnings in the past year.
  • CXT had a positive operating cash flow in the past year.
  • CXT had positive earnings in each of the past 5 years.
  • In the past 5 years CXT always reported a positive cash flow from operatings.
CXT Yearly Net Income VS EBIT VS OCF VS FCFCXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

  • The Return On Assets of CXT (5.30%) is better than 72.58% of its industry peers.
  • The Return On Equity of CXT (12.74%) is better than 80.65% of its industry peers.
  • The Return On Invested Capital of CXT (8.78%) is better than 79.03% of its industry peers.
  • CXT had an Average Return On Invested Capital over the past 3 years of 11.44%. This is above the industry average of 8.85%.
Industry RankSector Rank
ROA 5.3%
ROE 12.74%
ROIC 8.78%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.14%
ROE(5y)16.86%
ROIC(3y)11.44%
ROIC(5y)10.83%
CXT Yearly ROA, ROE, ROICCXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

  • Looking at the Profit Margin, with a value of 9.80%, CXT belongs to the top of the industry, outperforming 84.68% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CXT has grown nicely.
  • With an excellent Operating Margin value of 17.59%, CXT belongs to the best of the industry, outperforming 92.74% of the companies in the same industry.
  • In the last couple of years the Operating Margin of CXT has grown nicely.
  • CXT has a Gross Margin of 43.20%. This is in the better half of the industry: CXT outperforms 75.81% of its industry peers.
  • In the last couple of years the Gross Margin of CXT has grown nicely.
Industry RankSector Rank
OM 17.59%
PM (TTM) 9.8%
GM 43.2%
OM growth 3Y-11.5%
OM growth 5Y9.05%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
CXT Yearly Profit, Operating, Gross MarginsCXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CXT is still creating some value.
  • The number of shares outstanding for CXT has been increased compared to 1 year ago.
  • Compared to 5 years ago, CXT has less shares outstanding
  • Compared to 1 year ago, CXT has a worse debt to assets ratio.
CXT Yearly Shares OutstandingCXT Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CXT Yearly Total Debt VS Total AssetsCXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • CXT has an Altman-Z score of 2.08. This is not the best score and indicates that CXT is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.08, CXT is in line with its industry, outperforming 41.13% of the companies in the same industry.
  • The Debt to FCF ratio of CXT is 6.27, which is on the high side as it means it would take CXT, 6.27 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of CXT (6.27) is comparable to the rest of the industry.
  • CXT has a Debt/Equity ratio of 0.89. This is a neutral value indicating CXT is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.89, CXT is doing worse than 87.10% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.27
Altman-Z 2.08
ROIC/WACC0.96
WACC9.11%
CXT Yearly LT Debt VS Equity VS FCFCXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that CXT should not have too much problems paying its short term obligations.
  • CXT has a Current ratio of 1.26. This is amonst the worse of the industry: CXT underperforms 80.65% of its industry peers.
  • CXT has a Quick Ratio of 1.26. This is a bad value and indicates that CXT is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CXT's Quick ratio of 0.94 is on the low side compared to the rest of the industry. CXT is outperformed by 80.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.94
CXT Yearly Current Assets VS Current LiabilitesCXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

4

3. Growth

3.1 Past

  • The earnings per share for CXT have decreased by -4.92% in the last year.
  • Measured over the past 5 years, CXT shows a small growth in Earnings Per Share. The EPS has been growing by 1.12% on average per year.
  • Looking at the last year, CXT shows a quite strong growth in Revenue. The Revenue has grown by 11.43% in the last year.
  • CXT shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.71% yearly.
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%

3.2 Future

  • CXT is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.53% yearly.
  • CXT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.38% yearly.
EPS Next Y11.95%
EPS Next 2Y11.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.98%
Revenue Next 2Y5.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CXT Yearly Revenue VS EstimatesCXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
CXT Yearly EPS VS EstimatesCXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

8

4. Valuation

4.1 Price/Earnings Ratio

  • CXT is valuated reasonably with a Price/Earnings ratio of 11.89.
  • 91.13% of the companies in the same industry are more expensive than CXT, based on the Price/Earnings ratio.
  • CXT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.10.
  • A Price/Forward Earnings ratio of 10.62 indicates a reasonable valuation of CXT.
  • Based on the Price/Forward Earnings ratio, CXT is valued cheaper than 91.13% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of CXT to the average of the S&P500 Index (28.06), we can say CXT is valued rather cheaply.
Industry RankSector Rank
PE 11.89
Fwd PE 10.62
CXT Price Earnings VS Forward Price EarningsCXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CXT is valued cheaper than 88.71% of the companies in the same industry.
  • 87.10% of the companies in the same industry are more expensive than CXT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.06
EV/EBITDA 9.22
CXT Per share dataCXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The excellent profitability rating of CXT may justify a higher PE ratio.
PEG (NY)0.99
PEG (5Y)10.62
EPS Next 2Y11.53%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

  • CXT has a Yearly Dividend Yield of 1.37%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 0.46, CXT pays a better dividend. On top of this CXT pays more dividend than 91.94% of the companies listed in the same industry.
  • CXT's Dividend Yield is slightly below the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 1.37%

5.2 History

  • On average, the dividend of CXT grows each year by 6.42%, which is quite nice.
  • CXT has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.42%
Div Incr Years0
Div Non Decr Years0
CXT Yearly Dividends per shareCXT Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 24.82% of the earnings are spent on dividend by CXT. This is a low number and sustainable payout ratio.
  • CXT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP24.82%
EPS Next 2Y11.53%
EPS Next 3YN/A
CXT Yearly Income VS Free CF VS DividendCXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
CXT Dividend Payout.CXT Dividend Payout, showing the Payout Ratio.CXT Dividend Payout.PayoutRetained Earnings

CRANE NXT CO

NYSE:CXT (2/27/2026, 8:04:00 PM)

After market: 48.29 0 (0%)

48.29

-1.17 (-2.37%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)02-11
Earnings (Next)05-05
Inst Owners114.42%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner Change3.38%
Market Cap2.77B
Revenue(TTM)1.66B
Net Income(TTM)154.70M
Analysts81.82
Price Target94.28 (95.24%)
Short Float %12.64%
Short Ratio9.41
Dividend
Industry RankSector Rank
Dividend Yield 1.37%
Yearly Dividend0.68
Dividend Growth(5Y)6.42%
DP24.82%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.72%
Min EPS beat(2)0.03%
Max EPS beat(2)1.41%
EPS beat(4)3
Avg EPS beat(4)1.08%
Min EPS beat(4)-1.06%
Max EPS beat(4)3.95%
EPS beat(8)6
Avg EPS beat(8)1.32%
EPS beat(12)10
Avg EPS beat(12)6.53%
EPS beat(16)13
Avg EPS beat(16)6.15%
Revenue beat(2)1
Avg Revenue beat(2)-0.28%
Min Revenue beat(2)-2.45%
Max Revenue beat(2)1.89%
Revenue beat(4)2
Avg Revenue beat(4)-0.1%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)2.69%
Revenue beat(8)4
Avg Revenue beat(8)0.56%
Revenue beat(12)6
Avg Revenue beat(12)0.73%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)0.92%
Valuation
Industry RankSector Rank
PE 11.89
Fwd PE 10.62
P/S 1.76
P/FCF 16.06
P/OCF 12.79
P/B 2.28
P/tB N/A
EV/EBITDA 9.22
EPS(TTM)4.06
EY8.41%
EPS(NY)4.55
Fwd EY9.41%
FCF(TTM)3.01
FCFY6.22%
OCF(TTM)3.78
OCFY7.82%
SpS27.5
BVpS21.14
TBVpS-9.06
PEG (NY)0.99
PEG (5Y)10.62
Graham Number43.95
Profitability
Industry RankSector Rank
ROA 5.3%
ROE 12.74%
ROCE 12.04%
ROIC 8.78%
ROICexc 9.45%
ROICexgc 35.12%
OM 17.59%
PM (TTM) 9.8%
GM 43.2%
FCFM 10.93%
ROA(3y)7.07%
ROA(5y)6.96%
ROE(3y)16.14%
ROE(5y)16.86%
ROIC(3y)11.44%
ROIC(5y)10.83%
ROICexc(3y)12.73%
ROICexc(5y)12.19%
ROICexgc(3y)46.7%
ROICexgc(5y)44.71%
ROCE(3y)14.96%
ROCE(5y)14.57%
ROICexgc growth 3Y-23.13%
ROICexgc growth 5Y12.65%
ROICexc growth 3Y-18.15%
ROICexc growth 5Y5.03%
OM growth 3Y-11.5%
OM growth 5Y9.05%
PM growth 3Y-16.95%
PM growth 5Y5.97%
GM growth 3Y-3.13%
GM growth 5Y3.98%
F-Score4
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 6.27
Debt/EBITDA 2.86
Cap/Depr 43.72%
Cap/Sales 2.8%
Interest Coverage 5.31
Cash Conversion 57.22%
Profit Quality 111.57%
Current Ratio 1.26
Quick Ratio 0.94
Altman-Z 2.08
F-Score4
WACC9.11%
ROIC/WACC0.96
Cap/Depr(3y)44.3%
Cap/Depr(5y)36.54%
Cap/Sales(3y)2.63%
Cap/Sales(5y)2.17%
Profit Quality(3y)119.51%
Profit Quality(5y)128.53%
High Growth Momentum
Growth
EPS 1Y (TTM)-4.92%
EPS 3Y-19.21%
EPS 5Y1.12%
EPS Q2Q%5.83%
EPS Next Y11.95%
EPS Next 2Y11.53%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.43%
Revenue growth 3Y7.33%
Revenue growth 5Y-9.71%
Sales Q2Q%19.49%
Revenue Next Year6.98%
Revenue Next 2Y5.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-0.68%
EBIT growth 3Y-5.02%
EBIT growth 5Y-1.54%
EBIT Next Year23.49%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y6.61%
FCF growth 3Y-11.36%
FCF growth 5Y-6.44%
OCF growth 1Y2.51%
OCF growth 3Y-7.59%
OCF growth 5Y-4.84%

CRANE NXT CO / CXT FAQ

What is the fundamental rating for CXT stock?

ChartMill assigns a fundamental rating of 6 / 10 to CXT.


Can you provide the valuation status for CRANE NXT CO?

ChartMill assigns a valuation rating of 8 / 10 to CRANE NXT CO (CXT). This can be considered as Undervalued.


What is the profitability of CXT stock?

CRANE NXT CO (CXT) has a profitability rating of 8 / 10.


How financially healthy is CRANE NXT CO?

The financial health rating of CRANE NXT CO (CXT) is 3 / 10.


Is the dividend of CRANE NXT CO sustainable?

The dividend rating of CRANE NXT CO (CXT) is 6 / 10 and the dividend payout ratio is 24.82%.